Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

eSSENTIAL Accessibility, Aeroplan partner to offer desktop app for people with physical disabilities

eSSENTIAL Accessibility is proud to announce its partnership with Aeroplan, Canada's premier coalition loyalty program.

23 Sep 2014

ACP and 20 other groups applaud Senate bill that ensures primary care access for women, children

The efforts and leadership of Senators Sherrod Brown (D-Ohio) and Patty Murray (D-Wash.) to ensure access to vital primary care services were lauded yesterday by the American College of Physicians and 20 other organizations, representing internal medicine and related subspecialties.

23 Sep 2014

Neuropathic pain phenotype identified in knee osteoarthritis

Some patients with knee osteoarthritis may experience neuropathic-like symptoms associated with central pain processing, reflecting a discrete phenotype, study findings suggest.

22 Sep 2014

Metabolic abnormalities predict severe hypertension

Components of the metabolic syndrome, as well as a family history of hypertension, identify people at risk of developing severe hypertension, say researchers.

22 Sep 2014

EYLEA Injection gets approval in Japan for treatment of myopic CNV

Regeneron Pharmaceuticals, Inc. today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd. has received approval from the Japanese Ministry of Health, Labour and Welfare for EYLEA (aflibercept) Injection for myopic choroidal neovascularization (myopic CNV).

22 Sep 2014

TSRI scientists devise new vancomycin-based antibiotic to rout resistant bacteria

Scientists at The Scripps Research Institute have devised a new antibiotic based on vancomycin that is powerfully effective against vancomycin-resistant strains of MRSA and other disease-causing bacteria.

18 Sep 2014

Researchers show link between childhood asthma and prenatal exposure to phthalates

Researchers at the Columbia Center for Children's Environmental Health at the Mailman School of Public Health are the first to demonstrate an association between childhood asthma and prenatal exposure to two phthalates used in a diverse array of household products. Results appear online in the journal Environmental Health Perspectives.

18 Sep 2014

Fat mass contributes to musculoskeletal pain risk

People with high fat mass could be at an increased risk of musculoskeletal pain, say researchers.

17 Sep 2014

Age confounds relationship between ambulatory and office BP

The relationship between ambulatory and office blood pressure varies with age, with the likelihood of white-coat hypertension increasing as people get older, a study shows.

17 Sep 2014

3SBio signs exclusive license agreement with JenKem for PEG-irinotecan

3SBio Inc., a leading biotechnology company based in China focusing on researching, developing, manufacturing and marketing biopharmaceutical products, announced today that it has entered into an exclusive license agreement with JenKem Technology Co., Ltd for the development, manufacturing and marketing in Mainland China of PEG-irinotecan, a long-acting polymer-drug conjugate which inhibits topoisomerase I (Topo-I).

17 Sep 2014

MOVANTIK tablets get FDA approval for treatment of OIC in patients with chronic, non-cancer pain

Nektar Therapeutics reported today that partner AstraZeneca today announced that the US Food and Drug Administration (FDA) approved MOVANTIK (naloxegol) tablets as the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) medication for the treatment of opioid-induced constipation (OIC), in adult patients with chronic, non-cancer pain.

16 Sep 2014

FDA grants Breakthrough Therapy designation to EYLEA Injection for treatment of diabetic retinopathy

Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted EYLEA (aflibercept) Injection Breakthrough Therapy designation for the treatment of diabetic retinopathy in patients with diabetic macular edema (DME).

16 Sep 2014

Patients with particular genetic variation more prone to drug-induced pancreatitis

Doctors have discovered that patients with a particular genetic variation are four times more likely to develop pancreatitis if they are prescribed a widely used group of drugs.

16 Sep 2014

GILZ protein key to preventing bone loss, researchers report

A small protein named GILZ appears to protect against the bone loss that often accompanies arthritis and its treatment, researchers report.

15 Sep 2014

People who take antidepressants are twice as likely to have dental implants fail

A team from McGill University has discovered that people who take the most common antidepressants (such as Celexa, Paxil, Lexapro, Prozac, and Zoloft, the Selective Serotonin Reuptake Inhibitors or SSRIs) are twice as likely to have dental implants fail as those who are not taking SSRIs.

12 Sep 2014

FDA approves Contrave extended-release tablets for chronic weight management

Takeda Pharmaceuticals U.S.A., Inc. and Orexigen® Therapeutics, Inc. jointly announced today that the U.S. Food and Drug Administration has approved Contrave® extended-release tablets as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index of 30 kg/m2 or greater (obese), or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition.

11 Sep 2014

AbbVie’s Phase 3 pivotal study shows HUMIRA is effective in reducing symptoms in HS

AbbVie today announced results from a Phase 3 pivotal study demonstrating that HUMIRA® (adalimumab) is effective in reducing common clinical signs and symptoms in moderate-to-severe hidradenitis suppurativa (HS), specifically the number of abscesses and inflammatory nodules.

11 Sep 2014

Researchers show how activation of receptor provokes bone degradation of rheumatoid arthritis

Researchers at the University of Illinois at Chicago College of Medicine have shown for the first time how the activation of a receptor provokes the inflammation and bone degradation of rheumatoid arthritis -- and that activation of this one receptor, found on cells in the fluid of arthritic joints, is all that is required.

11 Sep 2014

High sodium intake linked with more than doubled risk of developing rheumatoid arthritis

A new study published online in the journal Rheumatology today indicates that the interaction between high sodium intake and smoking is associated with a more than doubled risk of developing rheumatoid arthritis (RA).

11 Sep 2014

Study points to new therapeutic target to interrupt inflammation, bone erosion in rheumatoid arthritis

10 Sep 2014

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

eSSENTIAL Accessibility, Aeroplan partner to offer desktop app for people with physical disabilities

ACP and 20 other groups applaud Senate bill that ensures primary care access for women, children

Neuropathic pain phenotype identified in knee osteoarthritis

Metabolic abnormalities predict severe hypertension

EYLEA Injection gets approval in Japan for treatment of myopic CNV

TSRI scientists devise new vancomycin-based antibiotic to rout resistant bacteria

Researchers show link between childhood asthma and prenatal exposure to phthalates

Fat mass contributes to musculoskeletal pain risk

Age confounds relationship between ambulatory and office BP

3SBio signs exclusive license agreement with JenKem for PEG-irinotecan

MOVANTIK tablets get FDA approval for treatment of OIC in patients with chronic, non-cancer pain

FDA grants Breakthrough Therapy designation to EYLEA Injection for treatment of diabetic retinopathy

Patients with particular genetic variation more prone to drug-induced pancreatitis

GILZ protein key to preventing bone loss, researchers report

People who take antidepressants are twice as likely to have dental implants fail

FDA approves Contrave extended-release tablets for chronic weight management

AbbVie’s Phase 3 pivotal study shows HUMIRA is effective in reducing symptoms in HS

Researchers show how activation of receptor provokes bone degradation of rheumatoid arthritis

High sodium intake linked with more than doubled risk of developing rheumatoid arthritis

Study points to new therapeutic target to interrupt inflammation, bone erosion in rheumatoid arthritis

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in